Here are the 10-K annual reports from UFP Technologies Inc (UFPT) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow UFPT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full UFPT filings page.
UFP Technologies, Inc. files its annual report describing a fast-growing contract development and manufacturing business focused on single-use and single-patient medical devices for leading global OEMs. Its products support minimally invasive surgery, infection prevention, wound care, orthopedics, wearables and biopharma applications.
The company operates a global footprint of ISO 13485-certified and FDA-registered plants, including major facilities in the U.S., Dominican Republic, Mexico, Puerto Rico, Ireland and Costa Rica. Two customers, Intuitive Surgical SARL and Stryker, accounted for approximately 24.3% and 21.5% of 2025 net sales, while the top ten customers represented 68.8%, underscoring significant customer concentration risk.
Market capitalization held by non‑affiliates was about $1,814,993,392 as of June 30, 2025, based on a $244.16 share price, with 7,713,300 shares outstanding in early 2026. The workforce expanded to 4,846 full‑time employees and 503 temporary workers, reflecting continued scaling.
Key risks highlighted include inflationary cost pressures, supply-chain and raw material dependence, geopolitical and climate-related disruptions, cybersecurity threats, heavy reliance on a few customers, regulatory and ESG developments, and challenges integrating acquisitions. The company discloses a February 2026 cyber incident that disrupted some IT systems but reports operations and financial condition remain materially intact so far.